PRESS RELEASE published on 04/25/2025 at 00:00, 1 year ago Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science Onco-Innovations Limited's subsidiary, Inka Health Corp., partners with AstraZeneca Canada for real-world evidence research in oncology. The new engagement showcases Inka Health's expertise in evidence translation and market access Oncology Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Real-world Evidence Research
BRIEF published on 04/18/2025 at 00:05, 1 year ago Onco-Innovations Partners with Dalton Pharma for PNKP Isotope Synthesis Cancer Research Onco-Innovations PNKP Technology Dalton Pharma Services ADME Studies
BRIEF published on 04/18/2025 at 00:05, 1 year ago Onco-Innovations s'associe à Dalton Pharma pour la synthèse de l'isotope PNKP Recherche Sur Le Cancer Onco-Innovations Technologie PNKP Services Pharmaceutiques Dalton Études ADME
PRESS RELEASE published on 04/18/2025 at 00:00, 1 year ago Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology Onco-Innovations partners with Dalton Pharma Services to synthesize heavy labelled PNKP inhibitor for increasing survival rate in colorectal cancer mice. Study showcases promising therapeutic potential Colorectal Cancer Survival Rate Onco-Innovations Dalton Pharma Services PNKP Inhibitor
BRIEF published on 04/17/2025 at 01:35, 1 year ago Onco-Innovations Plans $600,000 Private Placement Private Placement Warrants Regulatory Approval Securities Offering Corporate Funding
BRIEF published on 04/17/2025 at 01:35, 1 year ago Onco-Innovations prévoit un placement privé de 600 000 $ Placement Privé Offre De Titres Mandats Financement Des Entreprises Approbation Réglementaire
PRESS RELEASE published on 04/17/2025 at 01:30, 1 year ago Onco-Innovations Announces Private Placement Onco-Innovations Limited announces a non-brokered private placement of up to 400,000 units at $1.50 per unit, for gross proceeds of up to $600,000, with plans for cancer research and treatment advancements Private Placement Securities Oncology Cancer Research Onco-Innovations Limited
BRIEF published on 04/11/2025 at 00:05, 1 year ago Onco-Innovations' Inka Health Advances Real-World Oncology Research Clinical Trials Oncology Research Real-world Data Quantitative Bias Analysis Regulatory Assessments
BRIEF published on 04/11/2025 at 00:05, 1 year ago Inka Health, filiale d'Onco-Innovations, fait progresser la recherche en oncologie dans le monde réel. Essais Cliniques Recherche En Oncologie Données Du Monde Réel Analyse Des Biais Quantitatifs Évaluations Réglementaires
PRESS RELEASE published on 04/11/2025 at 00:00, 1 year ago Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research Onco-Innovations Limited announces groundbreaking study on adjusting bias in real-world oncology research, published in JAMA Network Open, offering a method to enhance clinical comparisons Bias Analysis Onco-Innovations Limited Real-world Oncology Research JAMA Network Open Clinical Comparisons
Published on 05/07/2026 at 22:05, 24 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 18:30, 3 hours 59 minutes ago Silver Storm Announces Mobilization of Underground Mine Development Contractors at La Parrilla
Published on 05/07/2026 at 16:35, 5 hours 54 minutes ago Caledonia Mining Corporation Plc New Corporate Video
Published on 05/07/2026 at 15:15, 7 hours 14 minutes ago ACCESS Newswire Launches ACCESS Insights & Analytics, AI-Powered Press Release Scoring Platform
Published on 05/07/2026 at 20:42, 1 hour 47 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 3 hours 43 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 18:35, 3 hours 54 minutes ago Seminole Hard Rock Casino Named Official Miami World Cup 2026™ Host City Supporter
Published on 05/07/2026 at 18:00, 4 hours 29 minutes ago Correction d’un communiqué du 05.05.2026 21:46 CET/CEST - E-PANGO: Composition du capital au 30 avril 2026
Published on 05/07/2026 at 19:15, 3 hours 14 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 hours 14 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 hours 23 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 hours 23 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 hours 29 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL